Cytomegalovirus: disease syndromes and treatment.
Drew
W L
WL
Laboratory Medicine and Medicine, University of California, San Francisco, USA.
Lalezari
J P
JP
D017088:AIDS-Related Opportunistic Infections / Q000150:complications / Q000188:drug therapy* / Q000517:prevention & control; D000998:Antiviral Agents / Q000627:therapeutic use*; D002493:Central Nervous System Diseases / Q000821:virology; D002825:Chorioretinitis / Q000821:virology; D000077404:Cidofovir; D003586:Cytomegalovirus Infections / Q000150:complications / Q000188:drug therapy* / Q000517:prevention & control; D003596:Cytosine / Q000031:analogs & derivatives / Q000627:therapeutic use; D004351:Drug Resistance; D017245:Foscarnet / Q000627:therapeutic use; D015774:Ganciclovir / Q000627:therapeutic use; D005767:Gastrointestinal Diseases / Q000821:virology; D006801:Humans; D063065:Organophosphonates; D009943:Organophosphorus Compounds / Q000627:therapeutic use; D011014:Pneumonia / Q000821:virology; D015229:Sexually Transmitted Diseases, Viral / Q000517:prevention & control
D000998:Antiviral Agents; D063065:Organophosphonates; D009943:Organophosphorus Compounds; D017245:Foscarnet; D003596:Cytosine; D000077404:Cidofovir; D015774:Ganciclovir